CONTACT US

The Netherlands (HQ)     Romania

Parkstraat 83, 2514 JG        17 C.A. Rosetti, 2nd District

The Hague                          Bucharest

P: +31 (0) 703 538 154        + 40 (0) 21 527 03 51

F: +31 (0) 703 538 333        + 40 (0) 21 527 03 10

                         

                          office@saberg.org

                           www.saberg.org

Saberg Clinical Research is a ​​​​trade name of InterEuropa Clinical Research BV

 © 2015 Goosh 

  • Twitter Saberg Clinical Research
  • LinkedIn Saberg Clinical Research

About us

The highly skilled and experienced team at Saberg Clinical Research includes:

 

  • MDs, PharmDs, and PhDs with a proven track record in drug development, medical monitoring, pharmacovigilance, and medical writing.

  • Internationally recognized consultants and scientific advisors.

  • An extensive network of investigators and research sites throughout Europe, the United States, and Canada. Our network of investigators includes specialists with an excellent record of scientific integrity and high patient enrollment rates.

  • Experienced and highly trained Project Managers and Clinical Research Associates (CRAs).

In addition, we are proud of our partnership with Fanny Viallard.

Sandrin Bergheanu

CEO

Sandrin Bergheanu, MD, PhD is a physician - clinical pharmacologist with more than 10 years of experience in drug development, including designing, executing, and managing clinical trials.

 

Sandrin graduated from the Carol Davila Medical School in Bucharest, Romania. He then worked at the University Hospital of Geneva (HUG), Switzerland before moving to the Cardiology Department at Leiden University Medical Center (LUMC) in Leiden, the Netherlands. While at LUMC, he obtained his PhD in Cardiovascular Research through a combined program at the Department of Cardiology and the Department of Clinical Epidemiology. Sandrin was trained as a clinical pharmacologist at the Centre for Human Drug Research (CHDR) in Leiden, the Netherlands and LUMC. Sandrin has also received extensive training in clinical epidemiology, clinical study design, and biostatistics. He has participated in the design, set-up, and execution of clinical studies for the pharmaceutical industry, medical device companies, and academic consortia.

 

Prior to founding Saberg Clinical Research, Sandrin was the Medical Director at Sticares (a Netherlands-based CRO that specializes in cardiovascular research) and clinical research physician/medical advisor at Eli Lilly and Company. At Sticares, Sandrin coordinated and supervised all medical activities in phase I, phase II, and large phase III trials.

 

Sandrin speaks English, Dutch, French, Italian and Romanian.

Publication list